PREP and infection: This highlights the urgent need for novel drugs with innovativemechanisms of action, specifically targeting cell infection pathways.The prolyl oligopeptidase of Trypanosoma cruzi (POPTc80) has emerged as a promising target for developing inhibitorsto block the parasite’s infection process.